Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug–drug interactions-Reference-Cited by-同舟云学术

Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug–drug interactions

Published:2018-08 Issue: Volume:154 Page:28-38
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Takaoka Naoki,Sanoh Seigo,Okuda Katsuhiro,Kotake Yaichiro,Sugahara Go,Yanagi Ami,Ishida Yuji,Tateno Chise,Tayama Yoshitaka,Sugihara Kazumi,Kitamura Shigeyuki,Kurosaki Mami,Terao Mineko,Garattini Enrico,Ohta Shigeru

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. Drug-metabolizing ability of molybdenum hydroxylases;Kitamura;Drug Metab. Pharmacokinet.,2006

2. Mammalian aldehyde oxidases: genetics, evolution and biochemistry;Garattini;Cell. Mol. Life Sci.,2008

3. Improving drug candidates by design : a focus on physicochemical properties as a means of improving compound disposition and safety;Meanwell;Chem. Res. Toxicol.,2011

4. Synopsis of some recent tactical application of bioisosteres in drug design;Meanwell;J. Med. Chem.,2011

5. Mitigating heterocycle metabolism in drug discovery;Jean;J. Med. Chem.,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors;Expert Opinion on Drug Safety;2023-12-14

2. Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation;Drug Metabolism and Disposition;2023-09-26

3. Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver;Xenobiotica;2023-04-03

4. Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents;Drug Metabolism and Disposition;2023-04-03

5. Role of Human Aldo-Keto Reductases and Nuclear Factor Erythroid 2-Related Factor 2 in the Metabolic Activation of 1-Nitropyrene via Nitroreduction in Human Lung Cells;Chemical Research in Toxicology;2023-01-24